Clinical inquiries. What steps can reduce morbidity and mortality caused by hip fractures?
Grover
Michael
M
Department of Family Medicine, Mayo Clinic Arizona, Scottsdale, USA.
Edwards
Frederick
F
Hitchcock
Kristin
K
Stevens
Mary M
MM
D000368:Aged; D000700:Analgesics / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000517:prevention & control; D002511:Cephalosporins / Q000627:therapeutic use; D003693:Delirium / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology; D004334:Drug Administration Schedule; D006220:Haloperidol / Q000627:therapeutic use; D006620:Hip Fractures / Q000453:epidemiology / Q000401:mortality* / Q000628:therapy*; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007902:Length of Stay / Q000706:statistics & numerical data; D010146:Pain / Q000453:epidemiology / Q000517:prevention & control / Q000523:psychology; D011182:Postoperative Care; D017410:Practice Guidelines as Topic; D011300:Preoperative Care; D020127:Recovery of Function; D012307:Risk Factors; D013924:Thrombophlebitis / Q000453:epidemiology / Q000517:prevention & control*
D000700:Analgesics; D014150:Antipsychotic Agents; D002511:Cephalosporins; D006220:Haloperidol